Mass critical care: pediatric considerations in extending and rationing care in public health emergencies

Robert K Kanter1, Arthur Cooper

  • 1Department of Pediatrics, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY 13210, USA. kanterr@upstate.edu

Insights

Mass critical care (MCC) strategies can improve outcomes during public health emergencies (PHEs) for children. Planning for pediatric needs, resource allocation, and age-appropriate equipment are crucial for effective pediatric mass critical care.

Area of Science:

  • Pediatric critical care
  • Public health preparedness
  • Disaster medicine

Background:

  • Public health emergencies (PHEs) pose unique challenges for pediatric critical care.
  • Existing hospital resources often fall short of estimated pediatric needs during PHEs.
  • Mass critical care (MCC) principles require adaptation for pediatric populations.

Purpose of the Study:

  • To apply and adapt Mass Critical Care (MCC) concepts for pediatric populations during Public Health Emergencies (PHEs).
  • To identify critical resource gaps and propose solutions for pediatric mass critical care.
  • To inform policy regarding pediatric critical care resource allocation and outcome goals in PHEs.

Main Methods:

  • Review and adaptation of existing Mass Critical Care (MCC) guidelines for pediatric application.
  • Analysis of pediatric-specific resource needs and potential equipment limitations (e.g., ventilators).
  • Evaluation of validated pediatric mortality prediction scores (e.g., Pediatric Index of Mortality 2) for rationing.

Main Results:

  • MCC can improve population outcomes in PHEs by prioritizing life-saving interventions.
  • Significant gaps exist in pediatric critical care resources compared to adult needs.
  • Age-appropriate equipment is essential, and adult equipment poses limitations for infants.
  • The Pediatric Index of Mortality 2 score is suitable for rationing interventions to maximize survival.

Conclusions:

  • Adapting MCC principles is vital for optimizing pediatric outcomes during PHEs.
  • Strategic planning, resource management, and specialized pediatric expertise are necessary for effective pediatric MCC.
  • Policymakers must establish clear population outcome goals, balancing lives saved with life-years saved.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.